Lauer UM - Search Results

1

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.

Carter ME, Hartkopf AD, Wagner A, Volmer LL, Brucker SY, Berchtold S, Lauer UM, Koch A. Carter ME, et al. Among authors: lauer um. Front Mol Biosci. 2022 Feb 11;9:826302. doi: 10.3389/fmolb.2022.826302. eCollection 2022. Front Mol Biosci. 2022. PMID: 35223990 Free PMC article.

2

Oncolytic virotherapy of gynecologic malignancies.

Hartkopf AD, Fehm T, Wallwiener D, Lauer U. Hartkopf AD, et al. Gynecol Oncol. 2011 Feb;120(2):302-10. doi: 10.1016/j.ygyno.2010.10.031. Epub 2010 Dec 8. Gynecol Oncol. 2011. PMID: 21145097 Review.

3

Oncolytic virotherapy of breast cancer.

Hartkopf AD, Fehm T, Wallwiener D, Lauer UM. Hartkopf AD, et al. Among authors: lauer um. Gynecol Oncol. 2011 Oct;123(1):164-71. doi: 10.1016/j.ygyno.2011.06.021. Epub 2011 Jul 20. Gynecol Oncol. 2011. PMID: 21764108 Review.

4

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

Berchtold S, Lampe J, Weiland T, Smirnow I, Schleicher S, Handgretinger R, Kopp HG, Reiser J, Stubenrauch F, Mayer N, Malek NP, Bitzer M, Lauer UM. Berchtold S, et al. Among authors: lauer um. J Virol. 2013 Mar;87(6):3484-501. doi: 10.1128/JVI.02106-12. Epub 2013 Jan 9. J Virol. 2013. PMID: 23302892 Free PMC article.

5

Primary resistance phenomena to oncolytic measles vaccine viruses.

Noll M, Berchtold S, Lampe J, Malek NP, Bitzer M, Lauer UM. Noll M, et al. Among authors: lauer um. Int J Oncol. 2013 Jul;43(1):103-12. doi: 10.3892/ijo.2013.1914. Epub 2013 Apr 23. Int J Oncol. 2013. PMID: 23612727

6

Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.

Weiland T, Lampe J, Essmann F, Venturelli S, Berger A, Bossow S, Berchtold S, Schulze-Osthoff K, Lauer UM, Bitzer M. Weiland T, et al. Among authors: lauer um. Int J Cancer. 2014 Jan 1;134(1):235-43. doi: 10.1002/ijc.28350. Epub 2013 Aug 7. Int J Cancer. 2014. PMID: 23797800

7

Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.

Yurttas C, Berchtold S, Malek NP, Bitzer M, Lauer UM. Yurttas C, et al. Among authors: lauer um. Hum Gene Ther Clin Dev. 2014 Jun;25(2):85-96. doi: 10.1089/humc.2013.127. Hum Gene Ther Clin Dev. 2014. PMID: 24933569

8

Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials.

Hartkopf AD, Fehm T, Wallwiener M, Lauer U. Hartkopf AD, et al. Geburtshilfe Frauenheilkd. 2012 Feb;72(2):132-136. doi: 10.1055/s-0031-1298281. Geburtshilfe Frauenheilkd. 2012. PMID: 25374430 Free PMC article.

9

Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma.

Ruf B, Berchtold S, Venturelli S, Burkard M, Smirnow I, Prenzel T, Henning SW, Lauer UM. Ruf B, et al. Among authors: lauer um. Mol Ther Oncolytics. 2015 Oct 7;2:15019. doi: 10.1038/mto.2015.19. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119111 Free PMC article.

10

Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus.

Ellerhoff TP, Berchtold S, Venturelli S, Burkard M, Smirnow I, Wulff T, Lauer UM. Ellerhoff TP, et al. Among authors: lauer um. Int J Oncol. 2016 Nov;49(5):1931-1944. doi: 10.3892/ijo.2016.3675. Epub 2016 Aug 31. Int J Oncol. 2016. PMID: 27601235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters